Data / Form D filings / RS BioTherapeutics Inc.
RS BioTherapeutics Inc.: Form D filings
RS BioTherapeutics Inc., a health care company in Cumberland, MD, filed 5 Form D notices with the SEC between 2022 and 2024. The latest, on October 9, 2024, reports $20,000 sold of a $2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 157 BALTIMORE STREET, Cumberland, MD, 21502
- Phone
- (717) 433-5390
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1932193
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2024 | New notice | $2,000,000 | $20,000 | $1,980,000 | 1 | Sep 26, 2024 | sec.gov |
| Oct 19, 2023 | Amendment | $5,000,000 | $1,105,000 | $3,895,000 | 5 | Oct 6, 2023 | sec.gov |
| Aug 10, 2023 | New notice | $10,000,000 | $250,000 | $9,750,000 | 1 | Jul 20, 2023 | sec.gov |
| Mar 22, 2023 | New notice | $10,000,000 | $100,000 | $9,900,000 | 1 | Nov 16, 2022 | sec.gov |
| Jun 21, 2022 | New notice | $4,000,000 | $685,021 | $3,314,979 | 6 | Jun 9, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Dean Guzman | Executive Officer | |
| H. Dean Hart | Executive Officer | |
| Curtis Rhine | Executive Officer | |
| Justin Dean Molignoni | Executive Officer, Director | |
| David Dean Freas | Director |
Other health care companies in Maryland that filed recently
- ColoWatch, Inc. /MD/ $1.3 million · Oct 19, 2026
- Aromha, Inc. $75,000 · Sep 24, 2026
- Functional Longevity Labs, Inc. $25,000 · Sep 21, 2026
- Terrace Systems, Inc. $250,000 · Sep 16, 2026
- Savannah Therapeutics, Inc $3.9 million · Sep 11, 2026
- Featherglass Health, Inc. $25,000 · Sep 4, 2026
Every Form D from the week of Oct 7, 2024 · All recent filings in Maryland · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what RS BioTherapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.